"Eicosapentaenoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
| Descriptor ID |
D015118
|
| MeSH Number(s) |
D10.212.302.380.410.385 D10.251.355.255.200 D10.251.355.337.290 D10.627.430.450.390
|
| Concept/Terms |
Eicosapentaenoic Acid- Eicosapentaenoic Acid
- Eicosapentanoic Acid
- Acid, Eicosapentanoic
- omega-3-Eicosapentaenoic Acid
- omega 3 Eicosapentaenoic Acid
- Timnodonic Acid
- 5,8,11,14,17-Eicosapentaenoic Acid
- 5,8,11,14,17-Icosapentaenoic Acid
|
Below are MeSH descriptors whose meaning is more general than "Eicosapentaenoic Acid".
Below are MeSH descriptors whose meaning is more specific than "Eicosapentaenoic Acid".
This graph shows the total number of publications written about "Eicosapentaenoic Acid" by people in this website by year, and whether "Eicosapentaenoic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 7 | 3 | 10 |
| 2018 | 5 | 1 | 6 |
| 2019 | 6 | 4 | 10 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Eicosapentaenoic Acid" by people in Profiles.
-
Omega-3 Index and Clinical Outcomes of Severe COVID-19: Preliminary Results of a Cross-Sectional Study. Int J Environ Res Public Health. 2021 07 21; 18(15).
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
-
The need for precision nutrition, genetic variation and resolution in Covid-19 patients. Mol Aspects Med. 2021 02; 77:100943.
-
Blood omega-3 fatty acids and death from COVID-19: A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2021 03; 166:102250.
-
Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment. Am J Case Rep. 2020 Dec 14; 21:e928422.
-
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep. 2020 10 03; 22(12):72.
-
Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach. Drug Dev Res. 2021 04; 82(2):217-229.
-
Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19? Medicina (Kaunas). 2020 Aug 19; 56(9).
-
Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection. Front Immunol. 2020; 11:1997.
-
Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med. 2020 08 20; 156:190-199.